Literature DB >> 2992945

Antibodies against synthetic peptides react with the second Epstein-Barr virus-associated nuclear antigen.

J Dillner, B Kallin, G Klein, H Jörnvall, H Alexander, R Lerner.   

Abstract

Five peptides were synthesized on the basis of amino acid sequences predicted from the transformation-associated BamHI WYH region of the genome of the Epstein-Barr virus (EBV). Antisera to two peptides deduced from a 1.6-kb open reading frame in the BamHI H fragment identified an 87 000-dalton nuclear polypeptide that was present in EBV-carrying cell lines that expressed the second EBV-determined nuclear antigen (EBNA-2). This polypeptide was not detected in cell lines that carried EBV variants with a deleted BamHI WYH region or in EBV-negative cell lines. Three peptides deduced from the 1.6-kb open reading frame reacted with human EBNA-positive sera, but not with EBNA-negative sera. Following affinity purification with the peptides, two of the corresponding human antibodies also reacted with the 87 000-dalton polypeptide.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992945      PMCID: PMC554422          DOI: 10.1002/j.1460-2075.1985.tb03855.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  29 in total

1.  DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

Authors:  R Baer; A T Bankier; M D Biggin; P L Deininger; P J Farrell; T J Gibson; G Hatfull; G S Hudson; S C Satchwell; C Séguin
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

2.  Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells.

Authors:  M Hummel; E Kieff
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

3.  Evidence for two classes of chromatin-associated Epstein-Barr virus-determined nuclear antigen.

Authors:  T C Spelsberg; T B Sculley; G M Pikler; J A Gilbert; G R Pearson
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

4.  Mapping of polypeptides encoded by the Epstein-Barr virus genome in productive infection.

Authors:  M Hummel; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

5.  Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies.

Authors:  G R Pearson; B Vroman; B Chase; T Sculley; M Hummel; E Kieff
Journal:  J Virol       Date:  1983-07       Impact factor: 5.103

6.  Stable expression in mouse cells of nuclear neoantigen after transfer of a 3.4-megadalton cloned fragment of Epstein-Barr virus DNA.

Authors:  W P Summers; E A Grogan; D Shedd; M Robert; C R Liu; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

7.  Antibodies against synthetic peptides as a tool for functional analysis of the transforming protein pp60src.

Authors:  T Tamura; H Bauer; C Birr; R Pipkorn
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

8.  One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain.

Authors:  K Hennessy; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen.

Authors:  J Dillner; L Sternås; B Kallin; H Alexander; B Ehlin-Henriksson; H Jörnvall; G Klein; R Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

10.  The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus.

Authors:  M D Jones; L Foster; T Sheedy; B E Griffin
Journal:  EMBO J       Date:  1984-04       Impact factor: 11.598

View more
  18 in total

1.  BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins.

Authors:  A Ricksten; B Kallin; H Alexander; J Dillner; R Fåhraeus; G Klein; R Lerner; L Rymo
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

2.  Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter.

Authors:  Wei Yue; Edward Gershburg; Joseph S Pagano
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells.

Authors:  T Dambaugh; F Wang; K Hennessy; E Woodland; A Rickinson; E Kieff
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

4.  Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.

Authors:  M Rowe; L S Young; K Cadwallader; L Petti; E Kieff; A B Rickinson
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

5.  A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus.

Authors:  M Bodescot; M Perricaudet; P J Farrell
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

6.  The analysis of EBV proteins which are antigenic in vivo.

Authors:  D Walls; M Perricaudet; F Gannon
Journal:  Nucleic Acids Res       Date:  1988-04-11       Impact factor: 16.971

7.  Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection.

Authors:  W Henle; G Henle; J Andersson; I Ernberg; G Klein; C A Horwitz; G Marklund; L Rymo; C Wellinder; S E Straus
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

8.  Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies--a prospective study.

Authors:  T Lehtinen; J Lumio; J Dillner; M Hakama; P Knekt; M Lehtinen; L Teppo; P Leinikki
Journal:  Cancer Causes Control       Date:  1993-05       Impact factor: 2.506

9.  The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3.

Authors:  K Kanda; T Decker; P Aman; M Wahlström; A von Gabain; B Kallin
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

10.  Mitosis-specific hyperphosphorylation of Epstein-Barr virus nuclear antigen 2 suppresses its function.

Authors:  Wei Yue; Matthew G Davenport; Julia Shackelford; Joseph S Pagano
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.